Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 132 publications
Comparative Efficacy of Belantamab Mafodotin in Combination With Bortezomib and Dexamethasone Versus Standards of Care in Patients With Third-Line or Later Relapsed/Refractory Multiple Myeloma.
Journal: American journal of hematology
Published: April 24, 2026
Infections Within 100 Days of Idecabtagene Vicleucel and Impact on Survival for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis.
Journal: Transplantation and cellular therapy
Published: April 03, 2026
Phase I Trial of Venetoclax and BEAM Followed by Autologous Stem Cell Transplant for High-Risk Non-Hodgkin Lymphoma.
Journal: Transplantation and cellular therapy
Published: January 28, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.
Journal: Blood cancer journal
Published: December 04, 2025
RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT.
Journal: Blood
Published: April 14, 2025
Semi-parametric testing for ordinal treatment effects in time-to-event data via dynamic Dirichlet process mixtures of the inverse-Gaussian distribution.
Journal: Statistical methods in medical research
Published: March 20, 2025
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703.
Journal: Blood advances
Published: January 21, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 03, 2025
Perspectives of Healthcare Providers and Patients with Relapsed/Refractory Multiple Myeloma on Treatment Priorities and Novel Therapies.
Journal: Patient preference and adherence
Published: December 21, 2024
Last Updated: 09/26/2026